Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00611052
Other study ID # KTL423-0
Secondary ID
Status Terminated
Phase N/A
First received January 28, 2008
Last updated April 19, 2016
Start date March 2008
Est. completion date December 2013

Study information

Verified date April 2016
Source National Institute for Health and Welfare, Finland
Contact n/a
Is FDA regulated No
Health authority Finland: Ethics Committee
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to assess the effect of a cognitive group intervention on prevention of major depression in 14-15-year-old adolescents. Moreover, the effect on other selected mental health parameters are investigated.


Recruitment information / eligibility

Status Terminated
Enrollment 65
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 14 Years to 16 Years
Eligibility Inclusion Criteria:

- mild to moderate level depressive symptoms (RBDI self-report scale)

- adequate knowledge of the Finnish language

- informed consent from the adolescent (all) and his/her parent (under 15 years)

- healthy controls comprise subjects with no depressive symptoms

Exclusion Criteria:

- ongoing major depression, dysthymia or bipolar disorder

- ongoing other severe psychiatric illness precluding group participation

- mental retardation

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Intervention

Behavioral:
the Adolescent Coping with Stress
A group cognitive intervention, manualized and highly structured. Includes 8 sessions (á 1.5 hours) and a booster session 6 months after termination of the actual intervention. Groups leaders are specifically trained for this course.
Treatment as usual
The usual treatment received by the adolescent with mild to moderate self-reported depressive symptoms in school health care.
Other:
usual health education
usual health education given by the school nurses, targeted for healthy controls with no depressive symptoms according to the self-report scale

Locations

Country Name City State
Finland Kuopio University Hospital and Kuopio University Kuopio
Finland Turku Primary Health care and Adolescent Psychiatric clinic Turku
Finland Vantaa Primary Health Care Vantaa

Sponsors (7)

Lead Sponsor Collaborator
National Institute for Health and Welfare, Finland City of Kuopio, City of Turku, City of Vantaa, Helsinki University, Kuopio University Hospital, University of Eastern Finland

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major depression (diagnostic interview) High level of depressive symptoms (self-report scale) 3 months, 6 months, 12months, 24 months, 36 months Yes
Secondary Suicidality (diagnostic interview, self-report scale) 3 months, 6 months, 12 months, 24 months, 36 months Yes
See also
  Status Clinical Trial Phase
Completed NCT01316926 - Paxil CR Bioequivalence Study Brazil Phase 1
Recruiting NCT06187454 - Transcranial Direct Current Stimulation for Depression N/A
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT05768126 - Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine Phase 4
Completed NCT03219879 - Telephone-administered Relapse Prevention for Depression N/A
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT00069459 - Seasonal Affective Depression (SAD) Study Phase 1
Recruiting NCT05503966 - Combining Antidepressants and Attention Bias Modification in Depression N/A
Recruiting NCT03001245 - Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents N/A
Completed NCT02939560 - TMS for Adults With Autism and Depression N/A
Completed NCT02452892 - Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) N/A
Completed NCT02542891 - European Comparative Effectiveness Research on Internet-based Depression Treatment N/A
Withdrawn NCT02238730 - Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT02306551 - Well Being And Resilience: Mechanisms of Transmission of Health and Risk
Completed NCT01407575 - Buprenorphine for Treatment Resistant Depression Phase 3
Completed NCT01597661 - Bupropion & Cardio Birth Defect (Slone) N/A
Completed NCT01093053 - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations N/A